摘要
背景:蛋白质法呢基转移酶(PFT)抑制剂已经成为恶性疟原虫(Pf)寄生虫引起的疟疾治疗的有力靶标。 目的:探讨对Pf-PFT靶标有活性的各种支架。 结果:迄今为止,已经开发了基于乙二胺,拟肽,二苯甲酮,苯甲酰胺,四氢喹啉,萘啶和氧四氢喹啉的七种抑制剂支架。 结论:得出结论:萘啶类药物是最有前景的药物。 此外,将疏水性分子如异戊二烯基引入蛋白质或化学化合物促进蛋白质 - 蛋白质和蛋白质 - 膜相互作用,从而使其成为新的治疗剂的良好候选物。 未来的研究应该集中在疾病而不是感染和传播的动力学上; 这将为疾病带来新的视野。
关键词: 恶性疟原虫,抗疟疾,蛋白质,法呢基转移酶,抑制剂
图形摘要
Current Drug Targets
Title:A Review on Plasmodium falciparum-Protein Farnesyltransferase Inhibitors as Antimalarial Drug Targets
Volume: 18 Issue: 14
关键词: 恶性疟原虫,抗疟疾,蛋白质,法呢基转移酶,抑制剂
摘要: Background: Protein farnesyltransferase (PFT) inhibitors have emerged as a potent target for the malaria treatment caused by the Plasmodium falciparum (Pf) parasite.
Objective: To explore the various scaffolds which are active against Pf-PFT target.
Result: Seven inhibitor scaffolds based on ethylenediamine, peptidomimetic, benzophenone, benzamide, tetrahydroquinoline, naphthyridine and oxy-tetrahydroquinoline, have been developed till date.
Conclusion: It is concluded that naphthyridine based drugs are the most promising one. Furthermore, introducing the hydrophobic molecules like isoprenyl groups to a protein or a chemical compound facilitate protein-protein and protein-membrane interactions thereby makes them good candidates as new therapeutics. The future research should focus on the disease rather than the infection and the dynamics of its transmission; this will bring a new vision about the disease.
Export Options
About this article
Cite this article as:
A Review on Plasmodium falciparum-Protein Farnesyltransferase Inhibitors as Antimalarial Drug Targets, Current Drug Targets 2017; 18 (14) . https://dx.doi.org/10.2174/1389450117666160823165004
DOI https://dx.doi.org/10.2174/1389450117666160823165004 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase
Anti-Cancer Agents in Medicinal Chemistry Targeting Translation for Treatment of Cancer - A Novel Role for IRES?
Current Cancer Drug Targets Network Pharmacology Analysis of Molecular Mechanism of Curcuma longa L. Extracts Regulating Glioma Immune Inflammatory Factors: Implications for Precise Cancer Treatment
Current Topics in Medicinal Chemistry Eicosanoids in Prevention and Management of Diseases
Current Molecular Medicine Radiation Exposure of Anaesthetists Visualised by Real-time Dosimetry
Current Medical Imaging Targetting Esophageal and Gastric Cancers with Monoclonal Antibodies
Current Topics in Medicinal Chemistry The Use of Fas Ligand, TRAIL and Bax in Gene Therapy of Prostate Cancer
Current Gene Therapy Reactive Oxygen Species: Physiological Roles in the Regulation of Vascular Cells
Current Molecular Medicine The Molecular Basis of Herpesviruses as Oncolytic Agents
Current Pharmaceutical Biotechnology Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?
Current Pharmacogenomics Gastrointestinal Stromal Tumors: A Paradigm for Therapeutic Options in Solid Organ Tumors
Mini-Reviews in Medicinal Chemistry Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
Current Cancer Drug Targets Retraction Notice: Clinical Strategies for Preventing Postoperative Nausea and Vomiting After Middle Ear Surgery in Adult Patients
Current Drug Safety CYLD-Mediated Signaling and Diseases
Current Drug Targets Proteomics and Epigenetic Mechanisms in Stem Cells
Current Proteomics Novel Agents in the Management of Lung Cancer
Current Medicinal Chemistry Epigenetic Effects of Cadmium in Cancer: Focus on Melanoma
Current Genomics Tumor-Receptor Imaging in Breast Cancer: A Tool for Patient Selection and Response Monitoring
Current Molecular Medicine Strategies on the Development of Small Molecule Anticancer Drugs for Targeted Therapy
Mini-Reviews in Medicinal Chemistry Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)